<DOC>
	<DOCNO>NCT00437892</DOCNO>
	<brief_summary>Elevated level D-dimer , marker procoagulant state , identified marker increase risk recurrent VTE . Statins proven antithrombotic property , suggest reduction several prothrombotic marker , include D-dimer , patient high risk arterial thrombosis . Such antithrombotic property could also observe patient high risk venous thrombosis . Aim study ass effect statins D-dimer level patient previous VTE oral anticoagulant treatment withdrawal .</brief_summary>
	<brief_title>Statins Reduce D-dimer Levels Patients With Venous Thrombosis</brief_title>
	<detailed_description>Patients single episode idiopathic VTE ( either DVT pulmonary embolism ) receive least 6 month adequate treatment oral anticoagulant , treatment withdrawal plan , LDL cholesterol level equal great 130 mg/dL randomize either atorvastatin , 40 mg , 1 tablet daily lipid lower diet lipid lower diet 3 month . On day oral anticoagulant treatment withdrawal ( Day 0 ) , enrol patient undergo measurement plasma D-dimer . At 30 day ± 3 ( Day 30 ) , patient undergo measurement D-dimer , CK , LDH , ALAT e ASAT clinical evaluation . At 90 day ± 7 ( Day 90 ) , patient undergo measurement D-dimer , total cholesterol , HDL cholesterol , LDL cholesterol , triglyceride ed clinical evaluation , CK , LDH , ALAT e ASAT . At 6 month ± 1 ( Day 180 ) , patient undergo clinical evaluation .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Fibrin fragment D</mesh_term>
	<criteria>Adult patient single episode idiopathic VTE ( either DVT pulmonary embolism ) receive least 6 month adequate treatment oral anticoagulant , treatment withdrawal plan , LDL cholesterol level equal great 130 mg/dL . Age 18 year , Pregnancy puerperium , Active malignancy , Need anticoagulant treatment ( unfractionated heparin , low molecular weight heparin ) , Presence transient risk factor VTE [ recent ( &lt; 3 month ) surgery , Trauma , Fractures , Acute medical disease immobilization , Pregnancy use oral contraceptive ] , Contraindications statin therapy , Chronic renal failure ( defined creatinine clearance &lt; 30 mL/min ) , Ongoing treatment statin fibrates , Major indication statin therapy [ history cardiovascular disease , diabetes , elevate cardiovascular risk accord ATP III criterion ( 19 ) ] , Life expectancy le 6 month , Geographic inaccessibility , Concomitant enrolment another clinical trial , Refused informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Statins</keyword>
	<keyword>secondary prevention</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>d-dimer</keyword>
</DOC>